Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micro-X is an Australian publicly traded imaging technology company developing and commercializing ultra-lightweight X-ray and CT systems for medical and security applications. Its core platform is Nano Electronic X-ray (NEX) Technology, a cold-cathode carbon nanotube-based X-ray platform that enables smaller, lighter, faster, and electronically controlled imaging systems. In healthcare, Micro-X markets the Rover Plus mobile digital radiography system and is advancing a portable Head CT for stroke imaging as well as a mobile full-body CT under an ARPA-H-funded program. Outside healthcare, it also develops security imaging products including Argus, a baggage CT scanner, and modular passenger checkpoint systems. The company designs and manufactures key subsystems including X-ray tubes, high-voltage generators, and switching technology, with vertically integrated operations in Adelaide and a commercial and government-facing presence in Seattle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micro-X.